14 articles
New study shows CGMs improve blood sugar control and birth outcomes compared to traditional glucose testing during pregnancy.
FDA-integrated CGMs provide superior accuracy and safety compared to non-approved devices flooding global markets.
Dr. Michael Snyder reveals how continuous glucose monitors and smartwatches can detect illness onset and optimize metabolic health.
Stanford geneticist Dr. Michael Snyder explains how individual biology determines metabolic responses to interventions.
Comprehensive review reveals autoimmune markers present before symptoms and highlights automated insulin delivery breakthroughs.
New study shows CGM metrics better predict diabetic nerve damage in the eye than traditional blood sugar tests alone.
New research reveals how sleep quality directly impacts glucose control, offering actionable insights for diabetes management.
Dr. Ben Bikman reveals how insulin resistance silently fuels chronic disease and the dietary strategies to reverse it.
Major study shows CGM users had dramatically lower rates of complications and death compared to traditional monitoring methods.
New review exposes stark disparities in diabetes care across Asia-Pacific, from insulin access to advanced technologies like CGM and pumps.
Machine learning analyzes glucose patterns to identify distinct metabolic subphenotypes in type 2 diabetes patients.
Massive study creates AI digital twins using continuous glucose monitoring, genetics, and lifestyle data to predict disease before symptoms appear.
